Moneycontrol PRO
HomeNewsTorrentpharmaceuticals

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Sun Pharma, sell banking stocks: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Sun Pharma and feels that all banking stocks are sell ideas.

  • Sell Strides Shasun, Torrent Pharma, Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Strides Shasun, Torrent Pharma and Aurobindo Pharma and feels that ITC may head lower and test Rs 260.

  • Sell Asian Paints, Wockhardt; buy HUL, IndusInd Bank: Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Asian Paints and Wockhardt and advises buying Hindustan Unilever, Lupin and IndusInd Bank.

  • Buy Sun Pharma, Cairn, Tata Steel, BoB, Torrent Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Cairn India, Tata Steel, Bank of Baroda and Torrent Pharma.

  • Buy Torrent Pharma, Hindustan Unilever; sell BEML: Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying Torrent Pharma and Hindustan Unilever and advises selling BEML.

  • Buy BPCL, Adani Port, Kotak Mahindra Bank: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may buy Adani Port, Aurobindo Pharma, BPCL, Torrent Pharma and Kotak Mahindra Bank.

  • Sell Torrent Pharma, Voltas; buy Bank of Baroda: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Torrent Pharma and Voltas and advises buying Bank of Baroda.

  • Prefer pharma, Alembic Pharma looks interesting: Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that there are opportunities in pharma stocks and feels that Alembic Pharma looks interesting.

  • Buy Bharat Forge, Mindtree: Sudip Bandopadhyay

    Sudip Bandopadhyay, Market Expert is of the view that one can buy Bharat Forge, Mindtree and Persistent Systems.

  • Go long in Torrent Pharma, advises Gaurav Bissa

    Gaurav Bissa of LKP Securities recommends going long in Torrent Pharma with a target of Rs 1480.

  • Hold Torrent Pharma, says Gaurang Shah

    According to Gaurang Shah of Geojit BNP Paribas Financial Services, one may hold Torrent Pharma.

  • Credit Suisse raises target, EPS on Torrent Pharma

    The brokerage says higher Abilify sales, Dahej addressing capacity constraints and 10 percent price increase in Elder portfolio are key. According to Credit Suisse important markets of Torrent Pharma in order of priority are India, the US, Brazil and Germany.

  • Buy Persistent Systems: Sudip Bandopadhyay

    Sudip Bandopadhyay, Market Expert recommends buying Persistent Systems.

  • Top buzzing midcap stocks to trade on November 18

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Infosys, Gammon India, GMR Infra, Dishman Pharmaceuticals and Chemicals, Torrent Pharmaceuticals, SpiceJet, Indigo & Jet Airways.

  • Prefer Aurobindo Pharma, Mindtree, SKS Micro: Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Aurobindo Pharma, Cadila Healthcare and Torrent Pharmaceuticals from pharmaceutical space.

  • Samvat 2072: SP Tulsian sees 100% return in Samkrg Piston, target Rs 300

    SP Tulsian of sptulsian.com is of the view that one may see Samkrg Pistons and Rings test Rs 300.

  • Samvat 2072: Top Diwali portfolio picks by Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one can add selective banks, auto, pharma and FMCG stocks in the portfolio.

  • Bull's Eye: Buy Tata Motors DVR, Divis Lab, NMDC, Wonderla

    CA Rudramurthy BV of Vachana Investments is of the view that one may buy Wonderla with a target of Rs 332.

  • Invest in Alembic Pharma, says Dipan Mehta

    Dipan Mehta, Member at BSE & NSE is of the view that one can invest in Alembic Pharma.

  • Like TCS, Infosys, Tata Motors, Sun Pharma: R Venkatraman

    R Venkatraman, MD at IIFL Group likes Tata Consultancy Services and Infosys in IT space, Maruti Suzuki and Tata Motors from the auto space and Sun Pharmaceutical Industries and Torrent Pharmaceuticals from the pharma space.

  • Top buzzing midcap stocks to trade on October 21

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Indiabulls Real Estate, Mphasis, Federal Bank, Torrent Pharma, Dr Reddys Laboratories & Aurobindo Pharma.

  • Expect upside in Torrent Pharma, says Hemen Kapadia

    Hemen Kapadia of KR Choksey Securities is of the view that one may expect upside in Torrent Pharma.

  • Dr Reddy's Labs top pick, says Mehraboon Irani

    Mehraboon Irani of Nirmal Bang Securities is of the view that Dr Reddy's Labs is the top pick.

  • Hold Torrent Pharma, may test Rs 1,800: Nooresh Merani

    According to Nooresh Merani of Analyse India, one may hold Torrent Pharma.

  • Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy

    Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347